Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 05, 2019

BUY
$43.37 - $59.54 $43,370 - $59,540
1,000 New
1,000 $54,000
Q2 2018

Jul 13, 2018

SELL
$40.53 - $50.7 $40,530 - $50,700
-1,000 Closed
0 $0
Q3 2017

Oct 12, 2017

BUY
$45.56 - $59.57 $45,560 - $59,570
1,000
1,000 $51,000

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.02B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Portfolio Solutions, LLC Portfolio

Follow Portfolio Solutions, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Portfolio Solutions, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Portfolio Solutions, LLC with notifications on news.